NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant (R34)
Post Date
September 16th 2011
Application Due Date
September 7th 2014
Funding Opportunity Number
PAR-11-338
CFDA Number(s)
93.121
Funding Instrument Type(s)
Grant
Funding Activity Categories
Eligibility Categories
State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Funding
-
Award Range:
$None - $None
Grant Description
The NIDCR will support R34 grants for the planning and design of clinical trials or biomarker clinical evaluation studies. The R34 grant award will provide support for activities that include, but are not limited to: the establishment of the research team; the development of the clinical protocol and Clinical Investigators Brochure (or equivalent); the development of tools for data management, safety and operational oversight of the research; the definition of recruitment strategies; and all essential elements of the study such as a Manual of Procedures for the clinical trial or biomarker clinical evaluation study, or a draft of the manualized behavioral, community, or services intervention. (See Scope for more detail.) The Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant is not designed for the collection of preliminary data (clinical or pre-clinical), or the collection of prospective data to support the rationale for a clinical trial or study.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
- More Information:
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: